Category: Blog

Bionest

The COVID-19 Health Crisis Continues: Long-Term Disease Impacts

Could "long COVID" be the world’s next health crisis? Data suggests that the health issues presented by the illness are perhaps even more widespread and serious than originally thought.

Bionest

Targeting Cancer: Interest in Radiopharmaceuticals on the Rise

Interest is rapidly growing in radiopharmaceuticals that target radiation directly to cancer cells throughout the body. How successful will they be?

Bionest

The Digital Pharmacy Boom

Amazon has been staking out a growing presence in healthcare. But the online giant is hardly alone in the digital pharmacy world. We take a look at the growing space.

Bionest

Increasing Role for PET

Positron emission tomography (PET) has become widely used for cardiac disease and several cancers. New sensitive antigen-specific tracers are further extending PET usefulness in other settings, including prostate cancer and Alzheimer’s disease (AD).

Bionest

Medical Device Technology and CNS Diseases

Deep brain stimulation, pulsed stimulation and wearable tremor-control devices... see how medical devices are transforming the treatment of central nervous system & psychiatric disorders.

Bionest

Growing Influence of Artificial Intelligence Throughout Pharma

Pharma’s use of artificial intelligence and machine learning is growing quickly. How and when should these tools be incorporated? We explore applications in target identification, drug discovery and optimization, clinical trials, manufacturing & commercialization.

Bionest

Pandemic Spurs Changes in EU Health Policy, Including Creation of EU “BARDA”

This year will see the formation of a new EU health program to strengthen the framework for ongoing coordination between states on measures aimed at disease protection, prevention, preparedness & response.

Bionest

What We’re Watching for in 2021 – Part 2 of 2

In our second post exploring trends we expect in the biotech and pharmaceutical development world in 2021, we take a look at digital health, the continuing impact of COVID-19, and growth in pharma investment.

Bionest

What We’re Watching for in 2021 – Part 1 of 2

mRNA therapeutics, psychadelics... what other pharmaceutical trends should we expect to see in 2021?

Bionest

Is it COVID-19? Flu? Or Perhaps, Both?

With flu season rapidly approaching, concerns are growing about the risks of a double coronavirus-influenza pandemic that could further overwhelm hospitals and other health care resources.